Alkermes plc
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products …
Biotechnology
IE, Dublin [HQ]
Ratios
14 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||
| Gross Margin | 72.27 | 72.04 | 67.29 | 46.06 | 27.62 | 23.07 | 30.36 | 37.16 | 45.00 | 40.80 | 44.85 | 48.55 | 80.38 | 82.64 | |
| Profit Margin | -22.23 | -24.40 | -29.15 | 4.34 | -4.86 | -36.15 | -27.95 | -17.48 | -12.73 | -16.79 | -10.67 | -4.10 | -14.24 | 21.39 | |
| Operating Margin | -24.14 | -24.45 | -22.64 | 14.21 | -14.08 | -35.70 | -27.98 | -16.37 | -9.06 | -13.84 | -10.82 | -2.27 | -12.80 | 24.90 | |
|
EPS Growth
|
-130.66 | -14.29 | -106.25 | 119.19 | -210.53 | -623.81 | 9.21 | 25.36 | 12.62 | -38.89 | 44.00 | 57.14 | -223.33 | 320.62 | |
| EPS USD | -42.00 | -48.00 | -99.00 | 19.00 | -21.00 | -152.00 | -138.00 | -103.00 | -90.00 | -125.00 | -70.00 | -30.00 | -97.00 | 214.00 | |
| Return on Assets (ROA) | -7.69 | -10.07 | -7.92 | 1.70 | -1.56 | -12.24 | -12.07 | -8.79 | -7.63 | -10.89 | -5.69 | -2.38 | -8.06 | 16.65 | |
| Return on Equity (ROE) | -9.60 | -11.62 | -13.31 | 2.62 | -2.15 | -17.28 | -17.23 | -13.13 | -11.89 | -18.11 | -10.39 | -4.33 | -15.16 | 29.58 | |
| Return on Invested Capital (ROIC) | -8.23 | -11.77 | -6.76 | 4.36 | -10.64 | -13.67 | -13.59 | -10.99 | -7.50 | -11.87 | -9.62 | -2.32 | -10.07 | 34.15 | |
| Solvency | |||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 9.90 | -2.74 | 30.97 | 25.10 | 18.63 | 18.86 | 16.43 | 15.66 | 15.30 | 15.35 | 14.10 | 14.61 | 14.93 | 13.61 | |
| Debt/Equity | 12.37 | -3.16 | 52.05 | 38.75 | 25.63 | 26.63 | 23.45 | 23.40 | 23.85 | 25.53 | 25.77 | 26.59 | 28.10 | 24.17 | |
| Debt/EBITDA | 73.71 | 89.49 | 5,215.48 | 156.50 | -457.97 | -103.41 | -66.44 | -99.27 | -46.88 | -68.63 | -3.82 | -363.34 | -0.83 | -34.26 | |
|
Debt/Capitalization
|
11.01 | -3.26 | 34.23 | 27.93 | 20.40 | 21.03 | 19.00 | 18.96 | 19.25 | 20.34 | 20.49 | 21.00 | 21.93 | 19.47 | |
| Long-Term Debt/Capitalization | - - | - - | 34.08 | 27.56 | 20.09 | 17.78 | 18.83 | 18.80 | 19.10 | 20.17 | 20.32 | 20.83 | 21.76 | 19.31 | |
| Interest Debt per Share USD | 0.60 | -0.10 | 4.12 | 3.17 | 2.59 | 2.43 | 1.97 | 1.91 | 1.90 | 1.85 | 1.79 | 1.91 | 1.87 | 1.89 | |
| Debt Growth | -32.74 | -100.00 | - - | -16.98 | -2.99 | -2.24 | -18.94 | -0.79 | -0.76 | -0.78 | -0.79 | 7.58 | -0.86 | -0.87 | |
| Liquidity | |||||||||||||||
| Current Ratio | 446.65 | 720.74 | 380.37 | 475.49 | 802.00 | 431.42 | 430.49 | 331.84 | 313.15 | 266.26 | 259.15 | 274.06 | 253.53 | 277.52 | |
| Quick Ratio | 336.49 | 466.72 | 321.69 | 402.62 | 599.41 | 292.23 | 324.70 | 229.15 | 247.15 | 204.66 | 210.97 | 183.09 | 181.89 | 214.61 | |
| Cash Ratio | 87.03 | 79.89 | 93.76 | 112.84 | 171.59 | 76.67 | 87.92 | 65.71 | 78.51 | 52.10 | 62.28 | 71.62 | 58.76 | 88.71 | |
| Operating Cash Flow Ratio | - - | - - | - - | 100 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Turnover | |||||||||||||||
| Inventory Turnover | 239.37 | 255.50 | 320.88 | 714.02 | 872.08 | 1,258.48 | 824.26 | 608.56 | 667.24 | 680.94 | 455.63 | 401.71 | 120.22 | 154.89 | |
| Receivables Turnover | 704.22 | 812.57 | 404.62 | 461.84 | 408.30 | 404.11 | 390.21 | 386.74 | 364.21 | 441.08 | 358.76 | 359.43 | 374.47 | 499.25 | |
| Payables Turnover | 603.12 | 563.01 | 693.36 | 1,698.28 | 1,385.11 | 1,292.46 | 1,122.14 | 1,022.29 | 1,513.38 | 1,277.56 | 1,244.52 | 1,083.82 | 664.09 | 439.80 | |
|
Asset Turnover
|
34.58 | 41.25 | 27.17 | 39.15 | 32.21 | 33.86 | 43.19 | 50.26 | 59.96 | 64.86 | 53.28 | 57.98 | 56.61 | 77.87 | |
| Fixed Turnover | 183.98 | 196.42 | 128.71 | 199.54 | 232.86 | 246.58 | 281.62 | 317.27 | 353.01 | 323.32 | 296.78 | 344.15 | 341.71 | 732.96 | |
| Coverage | |||||||||||||||
| Interest Coverage | -720.35 | -1,383.60 | -314.04 | 166.99 | -648.88 | -1,693.22 | -1,401.47 | -1,231.68 | -642.15 | -1,191.66 | -1,298.38 | -237.63 | -1,090.99 | 1,798.03 | |
| Asset Coverage | 900 | - - | 100 | 200 | 300 | 300 | 400 | 400 | 400 | 400 | 500 | 500 | 400 | 500 | |
| Cash Flow Coverage (CFGR) | -23.99 | 47.66 | -0.56 | 34.29 | 3.11 | -11.53 | -22.49 | 6.82 | 35.55 | 26.01 | 30.13 | 34.39 | 7.18 | 138.05 | |
| EBITDA Coverage | -600 | -1,300 | - - | 300 | -200 | -1,200 | -900 | -700 | -100 | -700 | -600 | 100 | -700 | 2,100 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | - - | - - | 100 | - - | - - | - - | - - | - - | - - | - - | - - | - - | 100 | |
| Market Prospects | |||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | -3.22 | -3.68 | -5.34 | 0.82 | -0.36 | -1.92 | -2.48 | -1.88 | -3.04 | -6.14 | -3.50 | -1.29 | -3.70 | 7.72 | |
|
Price/Earnings (P/E)
|
-3,104.18 | -2,718.82 | -1,871.71 | 12,168.02 | -27,885.71 | -5,213.87 | -4,039.21 | -5,316.03 | -3,285.71 | -1,629.46 | -2,857.74 | -7,771.62 | -2,700.07 | 1,296.12 | |
| Price/Earnings Growth (PEG) | 23.76 | -190.32 | -17.62 | -102.09 | 132.46 | -8.36 | 438.54 | 209.60 | 260.33 | -41.90 | 64.95 | 136.00 | -12.09 | -4.04 | |
|
Price/Book (P/B)
|
298.11 | 315.84 | 249.19 | 319.20 | 600.12 | 901.18 | 696.12 | 698.07 | 390.80 | 295.16 | 296.92 | 336.47 | 409.42 | 383.39 | |
| Price/Tangible Book (P/TB) | 298.11 | 315.84 | 249.19 | 319.20 | 600.12 | 901.18 | 696.12 | 698.07 | 390.80 | 295.16 | 296.92 | 336.47 | 409.42 | 383.39 | |
| Price/Sales (P/S) | 689.96 | 663.39 | 545.60 | 528.18 | 1,354.70 | 1,884.98 | 1,129.08 | 929.45 | 418.30 | 273.61 | 304.99 | 318.94 | 384.36 | 277.20 | |
|
Price/Cash Flow (P/CF)
|
-10,043.78 | -20,964.27 | -85,726.11 | 2,402.14 | 75,255.63 | -29,345.82 | -13,196.26 | 43,754.05 | 4,610.50 | 4,445.02 | 3,824.29 | 3,680.39 | 20,306.63 | 1,148.87 | |
| Price/Free CF (P/FCF) | -4,387.75 | -8,088.78 | -10,928.21 | 2,913.66 | -37,236.69 | -12,703.08 | -7,835.06 | -26,148.87 | 15,334.52 | -16,982.99 | 7,798.83 | 5,149.61 | -24,829.04 | 1,305.11 | |
| Price/Operating CF (P/OCF) | -10,043.78 | -20,964.27 | -85,726.11 | 2,402.14 | 75,255.63 | -29,345.82 | -13,196.26 | 43,754.05 | 4,610.50 | 4,445.02 | 3,824.29 | 3,680.39 | 20,306.63 | 1,148.87 |